Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Chaichana P. et al, (2021), Emerging infectious diseases, 27, 463 - 470
(2021), Nature, 589, 415 - 419
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Barrett JR. et al, (2020), Nature Medicine
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Ewer KJ. et al, (2020), Nature Medicine
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Current opinion in microbiology, 57, 95 - 101
Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries
Lim C. et al, (2020), Journal of Medical Internet Research, 22, e19762 - e19762
GBD 2019 Viewpoint Collaborators None., (2020), Lancet (London, England), 396, 1135 - 1159
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Demographics Collaborators None., (2020), Lancet (London, England), 396, 1160 - 1203
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Diseases and Injuries Collaborators None., (2020), Lancet (London, England), 396, 1204 - 1222
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Ainsworth M. et al, (2020), The Lancet Infectious Diseases
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Melioidosis DS rapid test: A standardized serological dipstick assay with increased sensitivity and reliability due to multiplex detection.
Wagner GE. et al, (2020), PLoS neglected tropical diseases, 14
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017
Reiner RC. et al, (2020), The Lancet, 395, 1779 - 1801
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
(2020), Nature Medicine, 26, 750 - 759
Human Immune Responses to Melioidosis and Cross-Reactivity to Low-Virulence Burkholderia Species, Thailand1.
Rongkard P. et al, (2020), Emerging infectious diseases, 26, 463 - 471